Infectious disease
Therapeutic area
Infectious Disease
Rare disease
No
- Definition
- A disorder directly resulting from the presence and activity of a microbial, viral, or parasitic agent in humans. It can be transmitted by direct or indirect contact.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Infectious disease
- Therapeutic area
- Infectious Disease
- infectious disease
- communicable disease
- infection
- infectious
- infectious disease
- infectious diseases and manifestations
- infectious disorder
- transmissible disease
- clinical infection
- Disease mechanisms
- Acquired
- All therapeutic areas
- Infectious Disease
- Severity
- Unknown
- MONDO ID
- MONDO:0005550
- Parent condition
- MONDO:7770010
Related records
Broader conditions (4)
- Disease
- Disease by etiologic mechanism
- Disease of primarily extrinsic mechanism
- Human disease
Narrower conditions (1,078)
- Abdominal tuberculosis
- Abscess
- Acanthamoeba infectious disease
- Acanthamoeba keratitis
- Acanthocephaliasis
- Acinetobacter infectious disease
- Acquired Creutzfeldt-Jakob disease
- Acquired human prion disease
- Actinobacillus infectious disease
- Actinomycetales infectious disease
- Actinomycosis
- Active tuberculosis
- Acute cystitis
- Acute disseminated encephalomyelitis
- Acute disseminated encephalomyelitis with anti-MOG antibodies
- Acute disseminated encephalomyelitis without anti-MOG antibodies
- Acute endophthalmitis
- Acute fibrinous and organizing pneumonia
- Acute gonococcal cervicitis
- Acute gonococcal cystitis
Trials (1,264)
- "Eye" Education for Parents and Myopia Control in Children
- "Healthcare APPlication for Children and Young People With Neuromotor Disabilities": a Digital Tool to Promote Integrated Pediatric Rehabilitation Care for Children and Young People With Disabilities and Their Families: a Mixed-methods Usability-acceptability-impact Study (HAPPY)
- 010Fit'R - Healthy Lifestyle Interventions for Children With Overweight
- 101-PGC-005 for the Treatment of COVID-19
- 18F-sodium Fluoride (NaF) PET to Replace Bone Scintigraphy: Safety and Efficacy Assessment
- 3D High Resolution Anorectal Manometry in Children After Surgery for Anorectal Disorders
- 3D High Resolution Manometry and Balloon Expulsion Test in Diagnosis of Dyssynergic Defecation in Children
- A Clinical Evaluation of the Safety and Efficacy of Randomized Placebo Versus the 8-aminoquinoline Tafenoquine for Early Symptom Resolution in Patients With Mild to Moderate COVID 19 Disease and Low Risk of Disease Progression
- A Clinical Trial Comparing the Efficacy of Tenofovir Disoproxil Fumarate/Emtricitabine/Rilpivirine (TDF/FTC/RPV) Versus TDF/FTC/Efavirenz (TDF/FTC/EFV) in Patients With Undetectable Plasma HIV-1 RNA on Current First-line Treatment
- A Clinical Trial to Evaluate the Safety and Immunogenicity of BG505 MD39.3, BG505 MD39.3 gp151, and BG505 MD39.3 gp151 CD4KO HIV Trimer mRNA Vaccines in Healthy, HIV-uninfected Adult Participants
- A Comparative Study of Adding Ipratropium to Salbutamol for the Treatment of Asthma Attack in Children
- A Comparison of C-MAC Videolaryngoscopy and Direct Laryngoscopy for Nasotracheal Intubation
- A Comparison of the Laryngeal Mask Airway (LMA) Proseal and LMA Supreme in Children
- A Comparison of the LMA Unique and LMA Supreme in Children
- A Dietitian-Driven Unified Nutritional Care Model (ADDUCE)
- A Digital Stewardship Strategy for Patients With Reported Penicillin Allergy
- A First in Human Study of the Safety and Tolerability of Single and Multiple Doses of BWC0977 in Healthy Volunteers
- A First-in-Human Study to Evaluate JCXH-105, an SrRNA-based Herpes Zoster Vaccine
- A Multifaceted Intervention to Reduce Obesity Among Preschool Children: Study Protocol for a Randomized Controlled Trial in Suzhou City
- A Multiple Dose Study of the Safety, Tolerability and PK of CMX157 in Healthy Subjects
Approved drugs (1)
- Fluocinolone acetonide
Drugs in development (33)
- Acalabrutinib Phase 1
- Amoxicillin Phase 3
- AZD-5099 Phase 1
- Azithromycin Phase 2
- Blood, whole Phase 3
- Brilacidin Phase 2
- Caffeine Phase 1
- Cefepime Phase 2
- Ceftolozane Phase 2
- Chlorhexidine Phase 3
- Ciprofloxacin Phase 3
- Efineptakin alfa Phase 1
- Favipiravir Phase 1
- Gedivumab Phase 2
- Hydroxychloroquine Phase 2
- INCB-9471 Phase 2
- Isopropyl alcohol Phase 3
- Lactobacillus acidophilus Phase 2
- Meropenem Phase 2
- Midazolam Phase 1
Other linked drugs (13)
- Auriclosene
- Avibactam sodium
- Azoximer bromide
- Brivudine
- Ceftazidime
- Cefuroxime
- Cefuroxime axetil
- Clavulanic acid
- Dextranomer
- Hydrogen peroxide
- Teicoplanin
- Tigecycline
- Vancomycin